Publications

Publications

Papers from 2022 onwards. Current and former lab members are in bold.

2026

  1. Retrotransposable element derepression distinguishes DNMT3A-mutant from TET2-mutant clonal haematopoiesis

    Hasan M, Durandeau S, Thompson IR, Roussotte H, Tsai YT, Seymen N, Gerlevik S, Bianchini N, Alishah K, Albuquerque MM, Lewis J, Bonganay L, Jakobsen NA, Zeisig B, Irshad S, Vyas P, So ECW, Iacoangeli A, Zheng X, Mackie S, Mok KY, Uksaite V, Handfield LF, Napolitani G, Carmichael J, Mufti GJ, Gandhi AK, Suragani RNVS, Quek L, Karimi MM

    GeroScience

  2. Phase I trial of autologous regulatory T cells for immune aplastic anemia

    Matto N, Gandhi S, Rzepkowska M, Gerlevik S, Karimi MM, Kulasekararaj A, Douiri A, Miller A, Duran L, Cui H, Lewis J, Kordasti S, Lombardi G, Napolitani G, Mufti GJ

    Haematologica 111(9):2966–2977

  3. Multilayer modeling reveals an endogenous retrovirus signature predictive of induction chemotherapy failure in AML

    Seymen N, Gerlevik S, Thompson IR, Albuquerque MM, Conti A, So CWE, Karimi MM

    Blood Neoplasia 3(3):100263

  4. Mechanisms of MCM2-7 helicase activation and initial DNA melting at near base-pair resolution

    Weekes C, Willerding L, Khadayate SP, Liebl K, Mossler A, Montoya A, Rauthe V, Karimi MM, Zacharias M, Ulrich HD, Speck C, Reuter LM

    Nature Communications 17:8984

  5. Clonal dynamics of hematopoiesis in aplastic anemia after immunosuppression and eltrombopag

    Kaya DE, Cook R, Iacobelli S, Napolitani G, Gerlevik S, Seymen N, Sicre de Fontbrune F, Griffin M, Frieri C, Halkes CJM, Recher C, Barraco F, Forcade E, Méar JB, Laurino M, Drexler B, Daguindau E, van Os M, Terwel S, Dufour C, Karimi MM, Kulasekararaj AG, Peffault de Latour R, Risitano AM, Mufti GJ

    NEJM Evidence 5(5)

  6. The transposable element–PARP axis underpins synthetic lethality and immunogenic vulnerability in blood cancer

    Zeisig BB, Karimi MM, So CWE

    Blood 147(18):2035–2040

2025

  1. Clinical response to azacitidine in MDS is associated with distinct DNA methylation changes in HSPCs

    Thoms JAI, Yan F, Hampton HR, Davidson S, Joshi S, Saw J, Sarowar CH, Lim XY, Nunez AC, Kakadia PM, Bhuyan GS, Zou X, Nguyen M, Ghodousi ES, Koch FC, Vafaee F, Thompson IR, Karimi MM, Pickford R, Raftery MJ, Hough S, Buckland G, Bailey M, Ghodke Y, Absar N, Vaughan L, Pasalic L, Fong CY, Kenealy M, Hiwase DK, Stoddart RI, Mohammed S, Lee L, Passam FH, Larsen SR, Spring KJ, Skarratt KK, Rebeiro P, Presgrave P, Stevenson WS, Ling S, Tiley C, Fuller SJ, Roncolato F, Enjeti AK, Hoenemann D, Lemech C, Jolly CJ, Bohlander SK, Curtis DJ, Wong JWH, Unnikrishnan A, Hertzberg M, Olivier J, Polizzotto MN, Pimanda JE

    Nature Communications 16:4451

  2. Prompt-based bioinformatics: a new interface for multi-omics analysis

    Awan AR, Oveisi M, Karimi MM

    Nature Reviews Genetics 26(12):807–808

  3. Immune cells display an abnormal maturation and a proinflammatory profile in telomere biology disorders

    Gomes WR, Hama S, Napolitani G, Tan A, Catto LFB, Donaires FS, Santana BA, Carvalho VS, Martinez EZ, Condino-Neto A, Karimi MM, Mufti GJ, Calado RT

    Blood Advances 9(19):4790–4805

  4. Transposable elements as novel therapeutic targets for PARPi-induced synthetic lethality in PcG-mutated blood cancer

    Zeisig B, Tsai CT, Virely C, Fung TKK, Akin AT, Troadec E, Jiao B, Thompson IR, Lau PNI, Li N, Charalambous A, Bomfim L, Lynch J, Georgiou A, Hoogeboom R, Lynn C, Zhang SY, Patten PE, Fisher C, Schuh A, Ogawa S, Mufti GJ, Karimi MM, So CWE

    Blood 146(11):1314–1330

  5. CRISPRa-mediated disentanglement of the Dux-MERVL axis in the 2C-like state, totipotency, and cell death

    Chammas P, Xie SQ, Sepulveda-Rincon LP, Leeke BJ, Dore MH, … Karimi MM, …

    Science Advances 11(51):eadu9092

2024

  1. Expression of most retrotransposons in human blood correlates with biological aging

    Tsai YT, Seymen N, Thompson IR, Zou X, Mumtaz W, Gerlevik S, Mufti GJ, Karimi MM

    eLife 13:RP96575

  2. Identification of novel myelodysplastic syndromes prognostic subgroups by integration of inflammation, cell-type composition, and immune signatures in the bone marrow

    Gerlevik S, Seymen N, Hama S, Mumtaz W, Thompson IR, Jalili SR, Kaya DE, Iacoangeli A, Pellagatti A, Boultwood J, Napolitani G, Mufti GJ, Karimi MM

    eLife 13:RP97096

  3. A 5:2 intermittent fasting regimen ameliorates NASH and fibrosis and blunts HCC development via hepatic PPARα and PCK1

    Gallage S, Ali A, Barragan Avila JE, Seymen N, Ramadori P, Joerke V, Zizmare L, … Karimi MM, …

    Cell Metabolism 36(6):1371–1393

  4. MCM2-7 loading-dependent ORC release ensures genome-wide origin licensing

    Reuter LM, Khadayate SP, Mossler A, Liebl K, Faull SV, Karimi MM, …

    Nature Communications 15:7306

2023

  1. ModEx: a general purpose computer model exploration system

    Younesy H, Pober J, Möller T, Karimi MM

    Frontiers in Bioinformatics 3:1153800

  2. Mouse HP1γ regulates TRF1 expression and telomere stability

    Stylianakis E, Chan JPK, Law PP, Jiang Y, Khadayate S, Karimi MM, …

    Life Sciences 331:122030

2022

  1. Cohesin couples transcriptional bursting probabilities of inducible enhancers and promoters

    Robles-Rebollo I, Cuartero S, Canellas-Socias A, Wells S, Karimi MM, …

    Nature Communications 13:4342

  2. Spontaneous cholemia in C57BL/6 mice predisposes to liver cancer in NASH

    Gallage S, Ali A, Barragan Avila JE, Herebian D, Karimi MM, Irvine EE, McHugh D, …

    Cellular and Molecular Gastroenterology and Hepatology 13(3):875–878

For a complete list, see Mehdi’s Google Scholar profile.